Empowering GPOs and distributors with Rapid, High-Sensitivity Drug Detection Tools
FDA-cleared, CLIA-waived diagnostics made in the U.S.—deployed system-wide in minutes.
Why Instanosis
- FDA Cleared, CLIA Waived (InstaStrip Fentanyl Urine)
- 95% sensitivity and specificity vs. LC-MS/MS
- Zero lab infrastructure required
- Cost-effective and scalable across enterprise settings
- Backed by NIH and validated by UCSF, Mayo, and Penn
Supports Triage, Toxicology, and Harm Reduction Across Care Settings
- Emergency Departments
- Psychiatric Units
- Inpatient Pharmacies
- Behavioral Health & Substance Use Clinics
- Community Outreach and Harm Reduction
Flexible Terms, Secure Supply Chain, and GPO-Friendly Pricing
- U.S. manufacturing = reliable fulfillment
- Contract flexibility for system-wide deployment
- Bulk pricing, formulary support, and value analysis materials available
- Supports DEA/CDC/NIDA-aligned initiatives
FXN 3-in-1 Strip (Powder/Liquid)
Fentanyl/Xylazine/Nitazene test strips for forensic and harm reduction applications.
Detects: Fentanyl, Xylazine, Nitazene
Format: Single strip, field deployable
Use: Forensic/field screening
InstaStrip Fentanyl Rapid Test (FDA cleared, CLIA-Waived)
A dipstick test for the qualitative detection of Fentanyl in human urine.
Use: Point-of-care overdose screening
Detection: 1.0 ng/mL
CLIA-Waived | FDA Cleared
FXN 3-in-1 Kit
Fentanyl/Xylazine/Nitazene test strips for forensic and harm reduction applications.
Includes: Swabs, vials, droppers, instructions
Designed for sample prep without lab tools
Let’s Talk About Bringing Instanosis to Your Member Hospitals
800-946-5430 | 📧 support@instanosis.com